Trial Profile
Efficacy of vedolizumab and methotrexate combination in patients with moderate to severe pediatric inflammatory bowel disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 May 2017
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary) ; Methotrexate
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 23 May 2017 New trial record
- 09 May 2017 Results presented at the Digestive Disease Week 2017